Navigation Links
ICU Medical, Inc. Plans to "Vigorously Seek to Collect Damages" in wake of Patent Infringement Victory Over RyMed Technologies
Date:5/14/2012

SAN CLEMENTE, Calif., May 14, 2012 /PRNewswire/ -- ICU Medical, (NASDAQ: ICUI) today announced that it would "vigorously seek to collect damages" as a result of its patent infringement victory over RyMed. ICU Medical filed a lawsuit in 2007 to stop RyMed Technologies from selling its patent-infringing In-Vision Plus needlefree connector.  And, although RyMed modified its device, the company still pursued the infringement claims against both the original and current devices.  On December 17, 2010, ICU Medical obtained a Federal jury verdict that RyMed's devices infringe on two of ICU Medical's patents and ICU Medical's patents are valid. 

The Court granted ICU Medical a limited new trial on the narrow question of whether RyMed's current device literally infringes one other of ICU Medical's patents ('866), and last week, a jury found that it does not.  ICU Medical has not decided whether it will appeal this limited verdict. 

"The new verdict does not impact any portion of the earlier verdict that RyMed's original and current devices infringe ICU's patents," explained Alison Burcar, ICU Medical's Vice President of Product Development. "In the next phase of this case, we will establish the monetary damages caused by RyMed's infringing activities, and then vigorously seek to collect those damages."

Media Contact: Tom McCall
Vice President, Marketing
949-291-8959
tmccall@icumed.com

About ICU Medical, Inc.: ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. ICU Medical's products improve patient outcomes by helping prevent bloodstream infections and protecting healthcare workers from exposure to infectious diseases or hazardous drugs. The company's complete product line include
'/>"/>

SOURCE ICU Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ConvaTec Announces Acquisition of AbViser Medical, LLC
2. Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC
3. Law Office of Brodsky & Smith, LLC Announces Investigation of Globus Medical, Inc.
4. Medical Breakthrough for Incontinence From InControl Medical, LLC Cleared by FDA
5. TriReme Medical, Inc. Receives FDA 510(K) Clearance for Chocolate PTA Balloon Catheter
6. Saladax Biomedical, Inc. Expands Distribution of My5-FU in Europe
7. BARRX Medical, Inc. Announces Definitive Agreement to be Acquired by Covidien
8. Novation Awards ICU Medical, Inc. a New Contract to Supply Members With a Complete Line of Clinically-Preferred Critical Care Products
9. Breaking Study: ICU Medical, Inc. ChemoClave® System Costs Less to Implement than any Closed System Transfer Device for the Safe Handling of Hazardous Drugs
10. Saladax Biomedical, Inc. Names Edward Chu, M.D., Chair of the Companys Scientific Advisory Board
11. China Sky One Medical, Inc. Elects Board Directors at its Annual Shareholders Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... DALLAS , April 1, 2015 /PRNewswire/ ... Research Report on Global Azithromycin Industry and ... Drug Industry reports added to Pharmaceutical category ... analysis, the report introduces Azithromycin basic information, ... industry overview, policy analysis, and news analysis, ...
(Date:4/1/2015)... 1, 2015 Jintian Pharmaceutical Group Limited ("Jintian ... Mr. Jin Dongtao, chairman and executive director purchased 40,000,000 ... of the existing entire issued share capital of the ... with the total amount of approximately HK$113 million. Upon ... will increase from 45.17% to 47.17%. ...
(Date:4/1/2015)... , Mar. 30, 2015 Research and Markets ... the "An Introduction to the Medical Device Directives" ... provides a detailed introduction to the European medical device ... are covered, the involvement of Notified Bodies, how to ... It will also cover the documentation necessary to apply ...
Breaking Medicine Technology:Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 2Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 3Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 4Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 5Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 2Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 4Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 5An Introduction to the Medical Device Directives Training: London, UK - 13th, 14th, 15th of May 2015 2
... Inc. (NYSE: WPI ) today announced ... reached a settlement with Mallinckrodt Inc. on outstanding ... Mallinckrodt,s Exalgo® (Hydromorphone Hydrochloride Extended-Release ) tablets.  Mallinckrodt ... the United States District Court for the District ...
... Pa., Jan. 26, 2012   ProPhase Labs, Inc., the ... October, November and December winners of its "Share Your Cause ... provides financial aid on charitable work in US communities, has ... Buddies of Milwaukie, OR; and Hannah,s Home of Mentor, OH ...
Cached Medicine Technology:Watson Reaches Settlement with Mallinckrodt Over Exalgo(R) 2Cold-EEZE® Cold Remedy Announces Winners in its "Share Your Cause Not Your Cold" Campaign 2Cold-EEZE® Cold Remedy Announces Winners in its "Share Your Cause Not Your Cold" Campaign 3Cold-EEZE® Cold Remedy Announces Winners in its "Share Your Cause Not Your Cold" Campaign 4
(Date:4/1/2015)... 2015 Taking an important step forward ... for Nursing Commission for Nursing Education Accreditation (NLN CNEA) ... first NLN CNEA Board of Commissioners. Working with executive ... 15-member board will provide leadership and direction to accreditation ... decisions for nursing programs that seek accreditation from the ...
(Date:4/1/2015)... IL, Bethesda, MD, Alexandria, VA (PRWEB) April 01, ... Clinical Pathology (ASCP), the College of American Pathologists ... the American Society of Clinical Oncology (ASCO) today ... on the use of molecular marker testing for ... evidence-based guideline will help establish standard molecular marker ...
(Date:4/1/2015)... April 01, 2015 Dr Roz Kamani, ... she is now offering her patients an opportunity to ... can participate in “Beauty Days”, which is an exclusive ... Roz Kamani’s Kitsilano Skin Care Clinic. It is attended ... patients about the latest products and services that are ...
(Date:4/1/2015)... 2015 Tempaper has joined forces with ... giving campaign that will raise critical funds to help ... disease across the United States. , Throughout the month ... Tempaperdesigns.com will automatically receive free domestic ground shipping ... urgently needed progress to children and adults affected by ...
(Date:4/1/2015)... IQ Formulations , one of the most highly regarded ... U.S., today is commending GNC for taking steps to boost ... herbal supplements.* GNC vowed that its new processes will look ... labeling on its products. , In response to this ... Jay Cohen said: , “In a lightly-regulated industry where ...
Breaking Medicine News(10 mins):Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 2Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 2Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 4Health News:Dr Roz Kamani Now Offers Patients The Opportunity to Learn About Latest Products and Services 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 3Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2
... 2009 Oral-B(R) Stages, the dental,professional,s #1 recommended ... a campaign in recognition of National Children,s Dental ... about the state of children,s,oral health in America, ... parents and,healthcare providers alike. In fact, tooth ...
... MILL VALLEY, Calif., Feb. 12 Kovarus, Inc., a ... cycling shop in,Mill Valley, today jointly announced the launch ... cycling while also increasing awareness of a good cause,the ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080708/AQTU138LOGO ) , ...
... Cohen, president of Cleveland-based PRN Funding, LLC, participated ... on to do three more educational factoring videos. ... via PRN Funding,s unique factoring YouTube channel ( ... Channel in place, PRN Funding,s three featured factoring ...
... Perspective and Future DirectionsRALEIGH, N.C., Feb. 12 ... Clinical Research Organization, will host a prominent panel of ... February 25. Discussions will include case scenarios on cutting ... applicable to other fields of infectious disease research.The agenda ...
... Services, Inc. (NYSE: WST ) announced today ... before the market opens on Thursday, February 19, 2009 ... the results and business expectations at 9:00 a.m. Eastern ... or (210)839-8398. The passcode is WST.A live broadcast of ...
... Alert and Focused on and off the Racetrack -KENILWORTH, ... ), maker of the top-selling allergy medicine, CLARITIN, announces ... of NASCAR star and long-time allergy sufferer Carl Edwards. ... symptoms, will drive the No. 99 CLARITIN Ford Fusion ...
Cached Medicine News:Health News:Oral-B Addresses Children's Oral Health Needs at All Stages of Development During National Children's Dental Health Month 2Health News:Oral-B Addresses Children's Oral Health Needs at All Stages of Development During National Children's Dental Health Month 3Health News:Oral-B Addresses Children's Oral Health Needs at All Stages of Development During National Children's Dental Health Month 4Health News:Oral-B Addresses Children's Oral Health Needs at All Stages of Development During National Children's Dental Health Month 5Health News:Oral-B Addresses Children's Oral Health Needs at All Stages of Development During National Children's Dental Health Month 6Health News:Biking for Fun, Sport, and Brain Tumor Awareness 2Health News:Biking for Fun, Sport, and Brain Tumor Awareness 3Health News:PRN Funding Introduces the PRN Funding YouTube Channel 2Health News:PRA International Speaking Event: Rational Drug Design and Development in Infectious Diseases 2Health News:West to Host 2008 Fourth Quarter Conference Call 2Health News:Claritin(R) Renews Sponsorship With Allergy Sufferer and NASCAR Star Carl Edwards 2Health News:Claritin(R) Renews Sponsorship With Allergy Sufferer and NASCAR Star Carl Edwards 3
The ENDO CLOSE™ trocar site closure device has application in laparoscopic procedures for approximation of tissues and percutaneous suturing for closing incision sites....
This ENDOLOOP suture has a suture type - 0 PDSII and a 1.5 inch diameter....
... long ligature inserted into a plastic tube. The plastic ... the other. The suture protrudes from the narrow end ... knot which becomes secure after the device is activated. ... the scored end of the plastic tube. The scored ...
... difficile Panel is an enzyme immunoassay used ... antigen (glutamate dehydrogenase) and toxin A in ... as an aid in the diagnosis of ... of the Triage Microbiology product line, designed ...
Medicine Products: